04.02.2015 Views

Dictionary of Evidence-based Medicine.pdf

Dictionary of Evidence-based Medicine.pdf

Dictionary of Evidence-based Medicine.pdf

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

100 <strong>Dictionary</strong> <strong>of</strong> <strong>Evidence</strong>-<strong>based</strong> <strong>Medicine</strong><br />

diagnosis or to restoring, correcting or modifying physiological functions<br />

in human beings or animals (see Article 1 <strong>of</strong> Directive 65/65/EEC).<br />

<strong>Medicine</strong>s Commission<br />

The <strong>Medicine</strong>s Commission is an advisory body set up to advise the UK<br />

ministers <strong>of</strong> health on drug licensing issues. Applications for drug licences<br />

are evaluated by the Secretariat <strong>of</strong> the <strong>Medicine</strong>s Control Agency with<br />

the advice <strong>of</strong> the Committee on Safety <strong>of</strong> <strong>Medicine</strong>s (CSM). When a licence<br />

application is rejected, the drug manufacturer concerned can lodge an appeal<br />

to the <strong>Medicine</strong>s Control Agency which is heard by the CSM with<br />

attendance by members <strong>of</strong> the Secretariat. If this appeal fails, the company<br />

concerned can further appeal to the <strong>Medicine</strong>s Commission. If the advice<br />

<strong>of</strong> the MC is accepted by the UK ministers <strong>of</strong> health (the licensing authority)<br />

then the only other option open to the manufacturer is the court <strong>of</strong> law.<br />

In a recent case <strong>of</strong> licensing <strong>of</strong> a benzodiazepine, the CSM recommended<br />

recall <strong>of</strong> a licence, the MC reversed it and at the final stage, the licensing<br />

authority decided to adopt the CSM's advice. The case then went to the<br />

High Court.<br />

Memphis indicators<br />

A set <strong>of</strong> indicators used by health authorities in the UK for assessing the<br />

quality <strong>of</strong> prescribing by general practitioners. The indicators are: (i) the<br />

percentage <strong>of</strong> total costs accounted for by drugs <strong>of</strong> limited clinical value (e.g.<br />

cerebral vasodilators, antidiarrhoeals); (ii) the percentage <strong>of</strong> costs accounted<br />

for by selected modified-release preparations deemed to <strong>of</strong>fer little advantage<br />

over conventional formulations (e.g. sustained-release non-steroidal<br />

anti-inflammatory agents and sustained-release salbutamol); (iii) the<br />

percentage <strong>of</strong> costs accounted for by selected combination products judged<br />

to be irrational or contributing little additional benefit relative to the single<br />

agents (e.g. diuretic-potassium combinations).<br />

Merit good<br />

A merit good is one whose consumption by others is regarded as useful<br />

and is encouraged by incentives, subsidy or coercion. An example is compulsory<br />

schooling or training.<br />

MeSH thesaurus<br />

MeSH is the abbreviation for Medical Subject Headings used in the<br />

thesaurus designed by the National Library <strong>of</strong> <strong>Medicine</strong> in Bethesda,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!